搜索临床试验以:Famitinib
总计57个结果
-
Second Affiliated Hospital of Xi'an Jiaotong University尚未招聘
-
Fudan UniversityChongqing University Cancer Hospital; Sun Yat-sen University; Peking University Cancer Hospital... 和其他合作者招聘中
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
Shanghai Chest Hospital尚未招聘
-
Jiangsu HengRui Medicine Co., Ltd.尚未招聘
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
Tianjin Medical University Cancer Institute and...Jiangsu HengRui Medicine Co., Ltd.主动,不招人
-
Peking University People's HospitalJiangsu HengRui Medicine Co., Ltd.; OrigiMed完全的
-
Fudan University主动,不招人
-
Jiangsu HengRui Medicine Co., Ltd.完全的
-
Peking University People's HospitalJiangsu HengRui Medicine Co., Ltd.; Peking University Shougang Hospital撤销
-
Peking University People's HospitalPeking University; Northwestern University未知对 Famitinib 和 Camrelizumab 的耐药性 | 疗效和毒性的生物标志物中国
-
Jiangsu HengRui Medicine Co., Ltd.Sun Yat-sen University; Shanghai Pulmonary Hospital, Shanghai, China暂停
-
Jiangsu HengRui Medicine Co., Ltd.Sun Yat-sen University完全的
-
Jiangsu HengRui Medicine Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical Sciences终止
-
Jiangsu HengRui Medicine Co., Ltd.Shanghai Pulmonary Hospital, Shanghai, China完全的
-
Jiangsu HengRui Medicine Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical Sciences完全的